These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 12552451)

  • 1. Whole blood bactericidal activity during treatment of pulmonary tuberculosis.
    Wallis RS; Vinhas SA; Johnson JL; Ribeiro FC; Palaci M; Peres RL; Sá RT; Dietze R; Chiunda A; Eisenach K; Ellner JJ
    J Infect Dis; 2003 Jan; 187(2):270-8. PubMed ID: 12552451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early bactericidal activity of high-dose rifampin in patients with pulmonary tuberculosis evidenced by positive sputum smears.
    Diacon AH; Patientia RF; Venter A; van Helden PD; Smith PJ; McIlleron H; Maritz JS; Donald PR
    Antimicrob Agents Chemother; 2007 Aug; 51(8):2994-6. PubMed ID: 17517849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The early bactericidal activity of anti-tuberculosis drugs: a literature review.
    Donald PR; Diacon AH
    Tuberculosis (Edinb); 2008 Aug; 88 Suppl 1():S75-83. PubMed ID: 18762155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Bacteriostatic activity of blood in patients with pulmonary tuberculosis during polychemotherapy].
    Bialik IV; Klimenko MT; Ginzburg TS
    Probl Tuberk; 1991; (5):25-9. PubMed ID: 1924237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The early bactericidal activity of amikacin in pulmonary tuberculosis.
    Donald PR; Sirgel FA; Venter A; Smit E; Parkin DP; Van de Wal BW; Mitchison DA
    Int J Tuberc Lung Dis; 2001 Jun; 5(6):533-8. PubMed ID: 11409580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of delayed treatment response in pulmonary tuberculosis: use of time to positivity values of Bactec cultures.
    Carroll NM; Uys P; Hesseling A; Lawrence K; Pheiffer C; Salker F; Duncan K; Beyers N; van Helden PD
    Tuberculosis (Edinb); 2008 Nov; 88(6):624-30. PubMed ID: 18456556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The early bactericidal activity of rifabutin measured by sputum viable counts in Hong Kong patients with pulmonary tuberculosis.
    Chan SL; Yew WW; Ma WK; Girling DJ; Aber VR; Felmingham D; Allen BW; Mitchison DA
    Tuber Lung Dis; 1992 Feb; 73(1):33-8. PubMed ID: 1326348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early bactericidal activity of delamanid (OPC-67683) in smear-positive pulmonary tuberculosis patients.
    Diacon AH; Dawson R; Hanekom M; Narunsky K; Venter A; Hittel N; Geiter LJ; Wells CD; Paccaly AJ; Donald PR
    Int J Tuberc Lung Dis; 2011 Jul; 15(7):949-54. PubMed ID: 21682970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Tuberculostatic test in the treatment of pulmonary tuberculosis with 1st and 2d class drugs].
    Gur'ian IE; Svitneva AS; Tarasova EF
    Probl Tuberk; 1971; 49(12):33-6. PubMed ID: 5003602
    [No Abstract]   [Full Text] [Related]  

  • 10. [The specific features of bacillary excretion and drug sensitivity in Mycobacterium tuberculosis in patients with recurrent pulmonary tuberculosis].
    Il'iuna TIa; Zhangireev AA; Sidorenko OA
    Probl Tuberk Bolezn Legk; 2008; (5):20-2. PubMed ID: 18711814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro drug resistance and response to therapy in pulmonary tuberculosis patients under a DOTS programme in south India.
    Aparna SB; Reddy VC; Gokhale S; Moorthy KV
    Trans R Soc Trop Med Hyg; 2009 Jun; 103(6):564-70. PubMed ID: 19243801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time to positivity in liquid culture predicts colony forming unit counts of Mycobacterium tuberculosis in sputum specimens.
    Diacon AH; van der Merwe L; Demers AM; von Groote-Bidlingmaier F; Venter A; Donald PR
    Tuberculosis (Edinb); 2014 Mar; 94(2):148-51. PubMed ID: 24456754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mycobactericidal activity of sutezolid (PNU-100480) in sputum (EBA) and blood (WBA) of patients with pulmonary tuberculosis.
    Wallis RS; Dawson R; Friedrich SO; Venter A; Paige D; Zhu T; Silvia A; Gobey J; Ellery C; Zhang Y; Eisenach K; Miller P; Diacon AH
    PLoS One; 2014; 9(4):e94462. PubMed ID: 24732289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Follow-up observation on relapse of smear negative pulmonary tuberculosis after short-course chemotherapy].
    Xu WG; Gao Z; Fan BD
    Zhonghua Jie He He Hu Xi Za Zhi; 2003 Feb; 26(2):74-6. PubMed ID: 12783655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time to detection of Mycobacterium tuberculosis in BACTEC systems as a viable alternative to colony counting.
    Pheiffer C; Carroll NM; Beyers N; Donald P; Duncan K; Uys P; van Helden P
    Int J Tuberc Lung Dis; 2008 Jul; 12(7):792-8. PubMed ID: 18544206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Park SK; Kim JH; Kang H; Cho JS; Smego RA
    Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjunctive use of celecoxib with anti-tuberculosis drugs: evaluation in a whole-blood bactericidal activity model.
    Naftalin CM; Verma R; Gurumurthy M; Hee KH; Lu Q; Yeo BCM; Tan KH; Lin W; Yu B; Seng KY; Lee LS; Paton NI
    Sci Rep; 2018 Sep; 8(1):13491. PubMed ID: 30202030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sputum conversion among patients with pulmonary tuberculosis: are there implications for removal of respiratory isolation?
    Fortún J; Martín-Dávila P; Molina A; Navas E; Hermida JM; Cobo J; Gómez-Mampaso E; Moreno S
    J Antimicrob Chemother; 2007 Apr; 59(4):794-8. PubMed ID: 17392354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and tolerability of daily-half dose linezolid in patients with intractable multidrug-resistant tuberculosis.
    Park IN; Hong SB; Oh YM; Kim MN; Lim CM; Lee SD; Koh Y; Kim WS; Kim DS; Kim WD; Shim TS
    J Antimicrob Chemother; 2006 Sep; 58(3):701-4. PubMed ID: 16857689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.